PIK3CG and neoplasm: Evidence also suggests the involvement of PAM is conserved across tumors of varying glial origin, provided that in vivo inducible expression of PI3K is capable of precipitating oligodendroglioma oncogenesis, while deletion of PI3K-inhibitory factor (PTEN) can facilitate substantially more aggressive tumor progression [103].